Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Coronary Heart Disease

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Coronary Heart Disease in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suna, S1
Sakata, Y1
Shimizu, M1
Nakatani, D1
Usami, M1
Matsumoto, S1
Mizuno, H1
Ozaki, K1
Takashima, S2
Takeda, H1
Tanaka, T1
Hori, M2
Sato, H1
Sanada, S1
Asanuma, H1
Minamino, T1
Node, K1
Okuda, H1
Shinozaki, Y1
Ogai, A1
Fujita, M1
Hirata, A1
Kim, J1
Asano, Y1
Mori, H1
Tomoike, H1
Kitamura, S1
Kitakaze, M1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Coronary Heart Disease

ArticleYear
Lymphotoxin-alpha3 mediates monocyte-endothelial interaction by TNFR I/NF-kappaB signaling.
    Biochemical and biophysical research communications, 2009, Feb-06, Volume: 379, Issue:2

    Topics: Androstadienes; Cell Adhesion; Cell Communication; Cells, Cultured; Chromones; Coronary Disease; End

2009
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
    Circulation, 2004, Oct-12, Volume: 110, Issue:15

    Topics: 5'-Nucleotidase; Adenosine Triphosphate; Androstadienes; Animals; Cardiotonic Agents; Chromones; Cor

2004